Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
AAPL$328.81-6.31(-1.83%)Stock Market Today: Stocks Set for Lower Open After Apple Earnings Disappoint3:43:11 AM ETINTC$60.58-5.79(-8.80%)Intel Stock's October Was Its Worst Month Since at Least 1980. History Says What Can Come Next.3:41:02 AM ETCRWD$242.14-8.62(-3.44%)CrowdStrike Delivers AI Security and Safety for the Enterprise3:37:03 AM ETCRWD$242.14-8.62(-3.44%)CrowdStrike to Acquire Fiddler to Deliver Agent Observability for AI Trust3:37:02 AM ETCRWD$242.14-8.62(-3.44%)CrowdStrike Introduces the AI Kill Switch for AI Safety3:35:02 AM ETTTE$93.25-2.55(-2.67%)United Arab Emirates: TotalEnergies Signs a Five‑year Liquefied Natural Gas Supply Agreement with ADNOC Gas3:31:04 AM ETAMZN$246.55+5.28(+2.20%)Amazon Thinks AWS Could Become a $1 Trillion Business. Here's Why.3:26:00 AM ETSHOP$157.23-1.27(-0.81%)Shopify Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts3:18:06 AM ETBHP$80.06+0.91(+1.15%)BHP Group Limited Sponsored ADR $BHP Stock: Bank Julius Baer & Co. Ltd Zurich Decreases Position3:07:15 AM ETRY$204.57+1.59(+0.78%)Royal Bank Of Canada $RY Shares Acquired by Bank Julius Baer & Co. Ltd Zurich3:07:12 AM ETGS$901.00+4.17(+0.47%)The Goldman Sachs Group, Inc. $GS Shares Bought by Bank Julius Baer & Co. Ltd Zurich3:07:11 AM ETCSCO$102.01-2.90(-2.77%)Cisco Systems, Inc. $CSCO Shares Bought by Aware Super Pty Ltd as trustee of Aware Super3:07:11 AM ETIBM$252.51-5.30(-2.06%)International Business Machines Corporation $IBM Stock Sold by Bank Julius Baer & Co. Ltd Zurich3:07:10 AM ETBLK$1,176.94+19.61(+1.71%)BlackRock $BLK Stock Bought by Bank Julius Baer & Co. Ltd Zurich3:07:10 AM ETTSLA$404.30+4.01(+1.00%)1,659 Tesla, Inc. $TSLA Shares Purchased by Bank Julius Baer & Co. Ltd Zurich3:07:10 AM ETDHR$227.97-4.26(-1.83%)Danaher Corporation $DHR Holdings Trimmed by Bank Julius Baer & Co. Ltd Zurich3:07:09 AM ETQCOM$163.68-2.71(-1.64%)Qualcomm Incorporated $QCOM Stock Sold by Aware Super Pty Ltd as trustee of Aware Super3:05:36 AM ETGOOG$279.21-0.18(-0.06%)Alphabet Inc. $GOOG Holdings Lessened by Americana Partners LLC3:05:35 AM ETMSFT$508.26-14.79(-2.83%)Microsoft Corporation $MSFT Holdings Boosted by Arizona State Retirement System3:05:33 AM ETGOOG$279.21-0.18(-0.06%)Alphabet Inc. $GOOG Stock: Aprio Wealth Management LLC Increases Position3:05:33 AM ETGOOG$279.21-0.18(-0.06%)Alphabet Inc. $GOOG Stock: Avestar Capital LLC Lowers Holdings3:05:33 AM ETMSFT$508.26-14.79(-2.83%)Microsoft Corporation $MSFT Stock Sold by Allworth Financial LP3:05:33 AM ETAMD$472.00-37.96(-7.52%)4,374 Advanced Micro Devices, Inc. $AMD Shares Purchased by Aware Super Pty Ltd as trustee of Aware Super3:05:31 AM ETBAC$49.57-0.44(-0.88%)Bank of America Corporation $BAC Stock: Aware Super Pty Ltd as trustee of Aware Super Increases Stake3:05:31 AM ET

VCRE · NASDAQ

Vicore Pharma Holding AB

$9.59 -0.21 (-2.14%)

Company overview

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Market cap
$271M
Employees
37
Headquarters
Solna
Website
vicorepharma.com
CEO
Ahmed Mousa
Listed
July 2, 2026
P/E
0.00
Dividend yield
0.00%

Price chart

7.4810.1612.8415.5218.20
VCRE 1D NASDAQ O9.79H9.79L9.58C9.59-0.21 (-2.14%)Vol3.26K

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
VCREVicore Pharma Holding AB Press release Vicore Announces the Nomination Committee for the 2027 Annual General Meeting ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore Pharma to Participate in the Guggenheim Annual Healthcare Innovation Conference and the Stifel Healthcare Conference ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore's Phase 2b ASPIRE Trial of Buloxibutid in IPF Passes Pre-Planned Futility Analysis and Remains on Track for Mid-2027 Topline Results ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore Pharma to Participate in the Chardan Healthcare Conference ACCESS Newswire
VCREVicore Pharma Holding AB Press release Increase in Number of Shares and Votes in Vicore Pharma ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore Pharma to Participate in Upcoming Healthcare Conferences ACCESS Newswire
VCREVicore Pharma Holding AB Press release Vicore Pharma to Present at the European Respiratory Society Congress 2026 Accesswire
VCREVicore Pharma Holding AB Stock news Evolution Metals & Technologies, Barfresh Food Group, Snap And Other Big Stocks Moving Lower In Monday's Pre-Market Session Benzinga
VCREVicore Pharma Holding AB Stock news Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session Benzinga
KRUS Stock news Kura Sushi Posts Weak Q3 Sales, Joins FuelCell Energy And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Benzinga
See more
FAQ

Questions about Vicore Pharma Holding AB

What does Vicore Pharma Holding AB do?
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
What is VCRE's market cap?
Vicore Pharma Holding AB (VCRE) is a listed stock with a live quote. The latest market cap on this page is $271M.
Where is Vicore Pharma Holding AB headquartered?
Vicore Pharma Holding AB is headquartered in Solna.
How do I get VCRE news from the API?
Call GET /v1/news?tickers=VCRE. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does VCRE news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for VCRE, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the VCRE price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs